Rituximab for the treatment of systemic sclerosis: urgent need for an international randomised controlled trial.

Lancet Rheumatol

Scleroderma Programme, Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

Published: July 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2665-9913(21)00149-1DOI Listing

Publication Analysis

Top Keywords

rituximab treatment
4
treatment systemic
4
systemic sclerosis
4
sclerosis urgent
4
urgent international
4
international randomised
4
randomised controlled
4
controlled trial
4
rituximab
1
systemic
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!